1-2 of 2
marginal zone b-cell lymphoma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma

Clinical Trials & Observations
Panayiotis Panayiotidis, George A. Follows, Luigina Mollica, Arnon Nagler, Muhit Özcan, Armando Santoro, Don Stevens, David Trevarthen, Florian Hiemeyer, Jose Garcia-Vargas, Barrett H. Childs, Pier Luigi Zinzani, Martin Dreyling
Journal: Blood Advances
Blood Adv (2021) 5 (3): 823–828.
https://doi.org/10.1182/bloodadvances.2020002910
Published: 2021
Includes: Supplemental data
Journal Articles

Resistance mechanism for ibrutinib in marginal zone lymphoma

Clinical Trials & Observations
Narendranath Epperla, Arwa Y. Shana’ah, Dan Jones, Beth A. Christian, Sabarish Ayyappan, Kami Maddocks, Jennifer A. Woyach
Journal: Blood Advances
Blood Adv (2019) 3 (4): 500–502.
https://doi.org/10.1182/bloodadvances.2018029058
Published: 2019
Includes: Supplemental data